Research Article

The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans

Kristy Lu

Kristy Lu

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne, University of Technology, Victoria, Australia

Search for more papers by this author
Marcus A. Gray

Marcus A. Gray

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne, University of Technology, Victoria, Australia

Search for more papers by this author
Chris Oliver

Chris Oliver

Blackmore's Ltd, NSW, Australia

Search for more papers by this author
David T. Liley

David T. Liley

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne, University of Technology, Victoria, Australia

Search for more papers by this author
Ben J. Harrison

Ben J. Harrison

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne, University of Technology, Victoria, Australia

Search for more papers by this author
Cali F. Bartholomeusz

Cali F. Bartholomeusz

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne, University of Technology, Victoria, Australia

Search for more papers by this author
K. Luan Phan

K. Luan Phan

Department of Psychiatry and Behavioural Neuroscience, Wayne State University, Detroit, MI, USA

Search for more papers by this author
Pradeep J. Nathan

Corresponding Author

Pradeep J. Nathan

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne, University of Technology, Victoria, Australia

Neuropsychopharmacology Laboratory, Brain Sciences Institute, Swinburne University of Technology, Melbourne, Australia.Search for more papers by this author
First published: 26 July 2004
Citations: 125

Abstract

L-Theanine (δ-glutamylethylamide) is one of the predominant amino acids ordinarily found in green tea, and historically has been used as a relaxing agent. The current study examined the acute effects of L-theanine in comparison with a standard benzodiazepine anxiolytic, alprazolam and placebo on behavioural measures of anxiety in healthy human subjects using the model of anticipatory anxiety (AA). Sixteen healthy volunteers received alprazolam (1 mg), L-theanine (200 mg) or placebo in a double-blind placebo-controlled repeated measures design. The acute effects of alprazolam and L-theanine were assessed under a relaxed and experimentally induced anxiety condition. Subjective self-reports of anxiety including BAI, VAMS, STAI state anxiety, were obtained during both task conditions at pre- and post-drug administrations. The results showed some evidence for relaxing effects of L-theanine during the baseline condition on the tranquil–troubled subscale of the VAMS. Alprazolam did not exert any anxiolytic effects in comparison with the placebo on any of the measures during the relaxed state. Neither L-theanine nor alprazalam had any significant anxiolytic effects during the experimentally induced anxiety state. The findings suggest that while L-theanine may have some relaxing effects under resting conditions, neither L-theanine not alprazolam demonstrate any acute anxiolytic effects under conditions of increased anxiety in the AA model. Copyright © 2004 John Wiley & Sons, Ltd.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.